Predictive and prognostic biomarkers in urological tumours-Reference-Cited by-同舟云学术

Predictive and prognostic biomarkers in urological tumours

Published:2023-12 Issue: Volume: Page:
ISSN:0031-3025
Container-title:Pathology
language:en
Short-container-title:Pathology

Author:

Cimadamore Alessia,Franzese Carmine,Di Loreto Carla,Blanca Ana,Lopez-Beltran Antonio,Crestani Alessandro,Giannarini Gianluca,Tan Puay Hoon,Carneiro Benedito A.,El-Deiry Wafik S.,Montironi Rodolfo,Cheng Liang

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference119 articles.

1. Nivolumab versus everolimus in advanced renal-cell carcinoma;Motzer;N Engl J Med,2015

2. Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinoma;Motzer;N Engl J Med,2019

3. 696O_PR nivolumab + cabozantinib vs sunitinib in first-line treatment for advanced renal cell carcinoma: first results from the randomized phase III CheckMate 9ER trial;Choueiri;Ann Oncol,2020

4. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor–targeted agents: results from a large, multicenter study;Heng;J Clin Oncol,2009

5. External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study;Heng;Lancet Oncol,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Programmed Cell Death Ligand 1 (PD-L1) Immunohistochemical Expression in Advanced Urothelial Bladder Carcinoma: An Updated Review with Clinical and Pathological Implications;International Journal of Molecular Sciences;2024-06-19

2. The Status of Spermatogenesis in Germ Cell Tumor Bearing Testis and Its Association with Metastatic Disease;Clinical Genitourinary Cancer;2024-06

3. Predictive and prognostic biomarkers in solid tumours;Pathology;2023-12